Chemotherapy News and Research RSS Feed - Chemotherapy News and Research

Chemotherapy, in its most general sense, is the treatment of disease by chemicals especially by killing micro-organisms or cancerous cells. In popular usage, it refers to antineoplastic drugs used to treat cancer or the combination of these drugs into a cytotoxic standardized treatment regimen.
UOW researchers testing therapeutic values of Ashtanga yoga for breast cancer survivors

UOW researchers testing therapeutic values of Ashtanga yoga for breast cancer survivors

Canada’s University of Windsor researchers are testing therapeutic values of Ashtanga yoga for survivors of breast cancer. [More]
Nanohyperthermia may prove effective as adjuvant cancer treatment with chemotherapy

Nanohyperthermia may prove effective as adjuvant cancer treatment with chemotherapy

The mechanical resistance of tumors and collateral damage of standard treatments often hinder efforts to defeat cancers. [More]
New active pharmaceutical ingredient may help against severe forms of testicular cancer

New active pharmaceutical ingredient may help against severe forms of testicular cancer

A new active pharmaceutical ingredient may help against severe forms of testicular cancer, which only respond inadequately to other therapies. [More]
IQWiG investigates benefit of biomarker tests to support decision on adjuvant chemotherapy

IQWiG investigates benefit of biomarker tests to support decision on adjuvant chemotherapy

The German Institute for Quality and Efficiency in Health Care (IQWiG) investigated the benefit of biomarker tests to support the decision for or against adjuvant systemic chemotherapy in certain breast cancer patients, that is, women with primary hormone receptor-positive, HER2-negative breast cancer and up to 3 affected lymph nodes. [More]
Fred Hutch’s new Evergreen Fund to promote commercialization of research into lifesaving therapies

Fred Hutch’s new Evergreen Fund to promote commercialization of research into lifesaving therapies

Fred Hutchinson Cancer Research Center announced its first-ever grants from its newly established Evergreen Fund to spur researchers' efforts to advance bold ideas toward creating or partnering with a commercial entity. [More]
Reduced radiation can maintain high cure rates in patients with HPV-related oropharyngeal cancers

Reduced radiation can maintain high cure rates in patients with HPV-related oropharyngeal cancers

Human papillomavirus-positive oropharynx cancers (cancers of the tonsils and back of the throat) are on rise. [More]
Whitehead Institute researchers identify mechanism underlying cancer drug-resistance

Whitehead Institute researchers identify mechanism underlying cancer drug-resistance

The use of proteasome inhibitors to treat cancer has been greatly limited by the ability of cancer cells to develop resistance to these drugs. [More]
New discovery could lead to effective drugs to prevent excessive lymphatic growth in cancer

New discovery could lead to effective drugs to prevent excessive lymphatic growth in cancer

Cancer cells spread to other sites in the body through promoting the growth of new 'roads' to travel on. [More]
DDF launches three grants to fund opportunities for gastric cancer research

DDF launches three grants to fund opportunities for gastric cancer research

Debbie's Dream Foundation: Curing Stomach Cancer, an international non-profit organization that raises awareness and funds for stomach cancer, launched three research grants totaling $300,000 for the 2016-2017 grant cycle. [More]
UCLA-led research finds promising results for more personalized head and neck cancer treatment

UCLA-led research finds promising results for more personalized head and neck cancer treatment

Researchers have found that people with advanced head and neck squamous cell carcinoma and the KRAS-variant inherited genetic mutation have significantly improved survival when given a short course of the drug cetuximab in combination with standard chemotherapy and radiation. [More]
Localized chemotherapy may be effective way to keep immune system intact, animal study suggests

Localized chemotherapy may be effective way to keep immune system intact, animal study suggests

In experiments on mice with a form of aggressive brain cancer, Johns Hopkins researchers have shown that localized chemotherapy delivered directly to the brain rather than given systemically may be the best way to keep the immune system intact and strong when immunotherapy is also part of the treatment. [More]
Scientists find explanation for vulnerability of children to collateral damage from cancer treatment

Scientists find explanation for vulnerability of children to collateral damage from cancer treatment

Despite many successes in treating pediatric cancer, young children remain at high risk for developing severe, long-lasting impairments in their brain, heart, and other vital organs from chemotherapy and radiation treatments. In adults, however, these tissues are relatively spared. [More]
UF Health researchers elucidate how some tumors bolster own blood supply

UF Health researchers elucidate how some tumors bolster own blood supply

As cancerous tumors fester in the body, they need an ever-increasing blood supply to deliver the oxygen and nutrients that fuel their growth. Now, a team led by University of Florida Health researchers has established how some tumors bolster their own blood supply. [More]
Agendia data reveals impact of MammaPrint on adjuvant treatment decisions in breast cancer patients

Agendia data reveals impact of MammaPrint on adjuvant treatment decisions in breast cancer patients

Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, has presented new prospective data demonstrating the strong impact of its 70-Gene Breast Cancer Recurrence assay, MammaPrint, and the corresponding 80-Gene Molecular Subtyping Assay BluePrint, in clinical decision-making for patients with early-stage breast cancer in Germany. [More]
Oncotype DX test can help guide treatment decisions and enable personalized care before breast cancer surgery

Oncotype DX test can help guide treatment decisions and enable personalized care before breast cancer surgery

New data presented at the 2016 San Antonio Breast Cancer Symposium (SABCS) demonstrate that analyzing tumor biology with the Oncotype DX test can identify patients unlikely to benefit from chemotherapy prior to breast cancer surgery (neoadjuvant setting) and guide treatment decisions without compromising outcomes. [More]
Special Issue on digestive cancers offers five articles from experts in Latin America

Special Issue on digestive cancers offers five articles from experts in Latin America

ecancermedicalscience has published a new Special Issue on digestive cancers in Latin America, bringing together five articles from experts in the region. [More]
Targeted alpha therapy shows promise in treatment of metastatic prostate cancer

Targeted alpha therapy shows promise in treatment of metastatic prostate cancer

Nearly three years of research have brought about remarkable results for the majority of 80 patients subjected to targeted alpha therapy of metastatic prostate cancer. [More]
Breast cancer patient finds new hope with potentially revolutionary treatment

Breast cancer patient finds new hope with potentially revolutionary treatment

City of Hope patient Susan Young has had a remarkable response to a potentially revolutionary new treatment, a combination of the p53 cancer vaccine and a drug that blocks a specific cancer-aiding protein. [More]
Hormone receptor could be potential biomarker for gastric cancer, research shows

Hormone receptor could be potential biomarker for gastric cancer, research shows

Scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, the Veterans Affairs Medical Center in Miami, and Shantou University Medical College in China, have shown that the hormone receptor GHRH-R could be a potential biomarker for gastric cancer, enabling earlier diagnoses and better staging. [More]
Simple blood test may help predict ovarian cancer patient’s response to chemotherapy treatment

Simple blood test may help predict ovarian cancer patient’s response to chemotherapy treatment

Scientists might be able to quickly predict how ovarian cancer patients are likely to respond to chemotherapy treatment using a simple blood test, according to a Cancer Research UK-funded study published in PLOS Medicine today (Tuesday). [More]
Advertisement
Advertisement